Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer—Results from the AGMT GASTRIC-5 Registry

Trastuzumab in combination with a platinum and fluorouracil is the treatment of choice for patients with advanced human epidermal growth factor receptor 2 (HER2) positive gastric cancer and gastroesophageal junction (GEJ) cancer. Pathological assessment of the HER2 status in gastric/GEJ cancer, howe...

Descripción completa

Detalles Bibliográficos
Autores principales: Huemer, Florian, Weiss, Lukas, Regitnig, Peter, Winder, Thomas, Hartmann, Bernd, Thaler, Josef, Piringer, Gudrun, Schmitt, Clemens A., Eisterer, Wolfgang, Gänzer, Hannes, Wüstner, Alois, Andel, Johannes, Jagdt, Björn, Ulmer, Hanno, Greil, Richard, Wöll, Ewald
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230156/
https://www.ncbi.nlm.nih.gov/pubmed/32235305
http://dx.doi.org/10.3390/jcm9040935

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7230156/
https://www.ncbi.nlm.nih.gov/pubmed/32235305
http://dx.doi.org/10.3390/jcm9040935

Ejemplares similares